Product Information

DEXTROAMP-AMPHET ER 25 MG CAP is a generic product labeled by Elite Laboratories, Inc., priced at $0.6123 per EA under NDC 64850051401. Its NADAC has been published 181 times since Jun 7, 2023.

FDA first approved this application on Dec 11, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEA Schedule CII

Strength

6.25; 6.25; 6.25; 6.25 mg/1; mg/1; mg/1; mg/1

NDC

64850051401

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA212037

FDA Approved

12/11/2019

TE Code

AB1

On Market Since

12/16/2019

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has been published 181 times since Jun 7, 2023, and over the history we have for it it has declined 11.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6123 per EA
All-time high$0.7537 (Mar 12, 2025)
All-time low$0.4173 (May 22, 2024)
52-week high$0.6123
52-week low$0.4895
Median price$0.5633
Average price$0.5813
Largest weekly change+30.3% (Dec 18, 2024)
Weeks tracked181
Tracking sinceJun 7, 2023

Price History

1W

+8.9%

1M

+25.1%

3M

+23.6%

6M

+12.5%

1Y

+17.7%

3Y

+7.8%

5Y

N/A

All

-11.9%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHET ER 25 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 25 MG CAP, manufactured by Elite Laboratories, Inc., is $0.6123 per EA (NDC 64850051401), effective Nov 18, 2026.

How has the price of DEXTROAMP-AMPHET ER 25 MG CAP changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has declined 11.9%. It has been tracked across 181 weekly CMS publications since Jun 7, 2023.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 25 MG CAP?

Since Jun 7, 2023, the NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has ranged from a low of $0.4173 (May 22, 2024) to a high of $0.7537 (Mar 12, 2025), with a median of $0.5633 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHET ER 25 MG CAP?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXTROAMP-AMPHET ER 25 MG CAP, is $0.5122 per EA — about 16% below DEXTROAMP-AMPHET ER 25 MG CAP.

Who manufactures DEXTROAMP-AMPHET ER 25 MG CAP?

DEXTROAMP-AMPHET ER 25 MG CAP (NDC 64850051401) is labeled by Elite Laboratories, Inc., and CMS classifies it as a generic product.